Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Feb;17(1):264-271.

Hepatic Retransplantation

B W Shaw  1 , R D Gordon, S Iwatsuki, T E Starzl
Affiliations

Hepatic Retransplantation

B W Shaw et al. Transplant Proc. 1985 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
Liver transplants per calendar year. ▩, Retransplants; ■, first grafts.
Fig 2
Fig 2
Liver retransplantation with cyclosporine and prednisone: primary disease categories. ▩, Retransplants; ■, first grafts.
Fig 3
Fig 3
Indications for liver retranplantation: cyclosporine era. ▨, Primary nonfunction, n = 11; ▩, technical failure, n = 10; ■, rejection, n = 28.
Fig 4
Fig 4
Indications for retransplantation.
Fig 5
Fig 5
Timing of retransplantation. •, Alive at >6 months; X, dead before six months
Fig 6
Fig 6
Major cause of death v cause for retransplantation
Fig 7
Fig 7
Actuarial survival after liver retransplantation, before and after the introduction of cyclosporineprednisone therapy. —*—, CYCLO-P, n = 49; --∘--, AZA-P, n = 21
Fig 8
Fig 8
Actuarial survival after liver retransplantation with cyclosporine and prednisone in pediatric and adult patients. —*—, One graft, pediatric; --∘--, one graft, adult; ··□··, retransplanted, pediatric; --▵--, retransplanted, adult
Fig 9
Fig 9
Actuarial survival after liver retransplantation with cyclosporine and prednisone: primary diagnostic categories. —*—, Biliary atresia: --∘--, primary biliary cirrhosis; ··□··, inborn errors of metabolism; --▵--, all patients; —·*·—; cirrhosis; —·∘·—, sclerosing cholangitis
Fig 10
Fig 10
Actuarial survival for liver transplantation, based on indications for graft replacement. —*—, Rejection, n = 28; --∘--, technical failure, n = 10; ··□··, primary nonfunction, n = 11
Fig 11
Fig 11
Effective liver retransplantation of actuarial survival. —*—. With retransplantation; --∘--, without retransplantation
Fig 12
Fig 12
Intact upper vena caval anastomosis with short cuff of vein from the liver being removed, which is left in place for anastomosis with the new organ
See this image and copyright information in PMC

References

    1. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Hepatology. 1982;2:614. - PMC - PubMed
    1. Shaw BW, Jr, Martin DJ, Marquez JM, et al. Ann Surg. 1984;200:524. - PMC - PubMed
    1. Calne RY, Williams R, Lindop M, et al. Br Med J. 1981;283:115. - PMC - PubMed
    1. Starzl TE, Klintmalm GBG, Weil R, III, et al. N Engl J Med. 1981;305:266. - PMC - PubMed
    1. Shaw BW, Jr, Hakala TR, Rosenthal JT, et al. Surg Gynecol Obstet. 1982;155:321. - PMC - PubMed

LinkOut - more resources